Expert recommendations for biological treatment in patients with psoriasis

被引：5

作者：

Podoswa-Ozerkovsky, Nancy ^{[1
]}

Amaya-Guerra, Mario ^{[2
]}

Barba-Gomez, Jose F. ^{[3
]}

Estrada-Aguilar, Lorena ^{[4
]}

Gomez-Flores, Minerva ^{[5
]}

Lopeztello-Santillan, Adriana L. ^{[6
]}

Maldonado-Garcia, Cesar ^{[7
]}

Rivera-Gomez, Monica, I ^{[8
]}

Villanueva-Quintero, Delfina G. ^{[9
]}

Leon-Dorantes, Gladys ^{[10
]}

机构：

[1] Inst Mexican Seguro Social, Serv Dermatol, Hosp Gen Reg 1, Ciudad De Mexico, Mexico

[2] Univ Monterrey, Ctr Salud & Desarrollo, Serv Dermatol, Nuevo Leon, Mexico

[3] Inst Dermatol Jalisco Dr Jose Barba Rubio, Zapopan, Jalisco, Mexico

[4] Hosp Reg Lic Adolfo Lopez Mateos, Inst Seguridad & Serv Sociales Trabajadores Estad, Serv Dermatol, Ciudad De Mexico, Mexico

[5] Univ Autonoma Nuevo Leon, Hosp Univ, Serv Dermatol, Nuevo Leon, Mexico

[6] Inst Seguridad Social Estado Mexico & Municipios, Serv Dermatol, Toluca, Estado De Mexic, Mexico

[7] Ctr Dermatol Dr Ladislao de la Pascua, Jefatura ClIn Psoriasis, Ciudad De Mexico, Mexico

[8] Hosp Especialidades Ctr Med La Raza, Ctr Med Nacl La Raza, Inst Mexican Seguro Social, Ciudad De Mexico, Mexico

[9] Invest Clin, Ctr Atenc Enfermedades Inflamatorias, Guadalajara, Jalisco, Mexico

[10] Unidad Innovac Clin & Epidemiol Estado Guerrero, Secretaria Salud, Guerrero, Mexico

来源：

GACETA MEDICA DE MEXICO | 2020年 / 156卷 / 05期

关键词：

Psoriasis; Psoriatic arthritis; Recommendations; Biological agents; Mexico; HEPATITIS-C INFECTION; NATIONAL PSORIASIS; MEDICAL BOARD; CERTOLIZUMAB PEGOL; RHEUMATOID-ARTHRITIS; ETANERCEPT TREATMENT; MONOCLONAL-ANTIBODY; REPORTED OUTCOMES; CLINICAL-RESPONSE; EFFICACY;

D O I：

10.24875/GMM.20000241

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In recent years, the introduction of a series of biological drugs for the treatment of psoriasis has considerably increased the therapeutic armamentarium of doctors, and thus a strongly positive impact on the control of this condition has been achieved. With the purpose to provide the best recommendations for the use of these biological agents in patients with psoriasis, the Mexican group of psoriasis experts, PSOMEX, has developed recommendations in order to improve the understanding and therapeutic positioning of this type of medications.

引用

页码：454 / 462

页数：9

共 59 条

[1]

[Anonymous], 2008, J Clin Aesthet Dermatol, V1, P50

[2] From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis [J].

Armstrong, April W. ;

Siegel, Michael P. ;

Bagel, Jerry ;

Boh, Erin E. ;

Buell, Megan ;

Cooper, Kevin D. ;

Duffin, Kristina Callis ;

Eichenfield, Lawrence F. ;

Garg, Amit ;

Gelfand, Joel M. ;

Gottlieb, Alice B. ;

Koo, John Y. M. ;

Korman, Neil J. ;

Krueger, Gerald G. ;

Lebwohl, Mark G. ;

Leonardi, Craig L. ;

Mandelin, Arthur M. ;

Menter, M. Alan ;

Merola, Joseph F. ;

Pariser, David M. ;

Prussick, Ronald B. ;

Ryan, Caitriona ;

Shah, Kara N. ;

Weinberg, Jeffrey M. ;

Williams, MaryJane O. U. ;

Wu, Jashin J. ;

Yamauchi, Paul S. ;

Van Voorhees, Abby S. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (02) :290-298

[3] Combining Biologic TherapiesWith Other Systemic Treatments in Psoriasis Evidence-Based, Best-Practice Recommendations From the Medical Board of the National Psoriasis Foundation [J].

Armstrong, April W. ;

Bagel, Jerry ;

Van Voorhees, Abby S. ;

Robertson, Andrew D. ;

Yamauchi, Paul S. .

JAMA DERMATOLOGY, 2015, 151 (04) :432-438

[4] Inhibition of TNFα does not induce viral reactivation in patients with chronic hepatitis C infection:: two cases [J].

Aslanidis, S. ;

Vassiliadis, T. ;

Pyrpasopoulou, A. ;

Douloumpakas, I. ;

Zamboulis, C. .

CLINICAL RHEUMATOLOGY, 2007, 26 (02) :261-264

[5] Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet? [J].

Barrea, Luigi ;

Balato, Nicola ;

Di Somma, Carolina ;

Macchia, Paolo Emidio ;

Napolitano, Maddalena ;

Savanelli, Maria Cristina ;

Esposito, Katherine ;

Colao, Annamaria ;

Savastano, Silvia .

JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13

[6] Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review [J].

Brunasso, Alexandra M. G. ;

Puntoni, Matteo ;

Gulia, Andrea ;

Massone, Cesare .

RHEUMATOLOGY, 2011, 50 (09) :1700-1711

[7] Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease [J].

Burmester, Gerd R. ;

Panaccione, Remo ;

Gordon, Kenneth B. ;

McIlraith, Melissa J. ;

Lacerda, Ana P. M. .

ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (04) :517-524

[8] The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis [J].

Campanati, A. ;

Ganzetti, G. ;

Di Sario, A. ;

Damiani, A. ;

Sandroni, L. ;

Rosa, L. ;

Benedetti, A. ;

Offidani, A. .

JOURNAL OF GASTROENTEROLOGY, 2013, 48 (07) :839-846

[9] Very low-calorie ketogenic diet may allow restoring response to systemic therapy in relapsing plaque psoriasis [J].

Castaldo, Giuseppe ;

Galdo, Giovanna ;

Aufiero, Felice Rotondi ;

Cereda, Emanuele .

OBESITY RESEARCH & CLINICAL PRACTICE, 2016, 10 (03) :348-352

[10] Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial [J].

Chaudhari, U ;

Romano, P ;

Mulcahy, LD ;

Dooley, LT ;

Baker, DG ;

Gottlieb, AB .

LANCET, 2001, 357 (9271) :1842-1847

← 1 2 3 4 5 6 →